Almost 2 Years Ago
1 Min Read
CLNN down -4%. Here's what's moving the stock:
Clene Inc (CLNN) is trading -4% lower at $3.98 today.
Clene Inc has been trading between a 52-week high of $10.46 and a 52-week low of $1.93. The stock has a market cap of $252 Million.
Clene is a clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Clene has innovated a novel nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. Clene has also advanced into the clinic an aqueous solution of ionic zinc and silver for anti-viral and anti-microbial uses.
Clene Inc has been trading between a 52-week high of $10.46 and a 52-week low of $1.93. The stock has a market cap of $252 Million.
Clene is a clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Clene has innovated a novel nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. Clene has also advanced into the clinic an aqueous solution of ionic zinc and silver for anti-viral and anti-microbial uses.
Headlines
Why Cannabis Companies Traded Higher; Here''s 60 Biggest Movers From Yesterday
Benzinga 07-15-22
GME Stock Rallies Ahead of July 22 GameStop Stock Split
InvestorPlace 07-14-22
GOOG, GOOGL Stocks Fall Ahead of the Google Stock Split
InvestorPlace 07-14-22
Why Is Clene (CLNN) Stock Soaring 23% Today?
InvestorPlace 07-14-22
Clene''s CNM-Au8 Shows Decreased Mortality Amyotrophic Lateral Sclerosis Patients
Benzinga 07-14-22
Recommended Articles
